The Role of Cannabis
We fully support the physician-supervised medical use of cannabis and cannabinoids for appropriate medical indications where there exists a strong rationale for use, preferably with existing preclinical and clinical data that supports its effectiveness over or equivalence to the current clinical standard-of-care. In general, we will not exclude patients from our treatment programs if they test positive for cannabinoids either upon entry or during our program. Our organization believes that appropriate physician-supervised medical use of cannabinoids will play a significant and very mainstream role in the future treatment of pain and drug dependence. However, our long-term goal for patients is not to swap one substance for another. Despite few serious harms and its relatively low addictive potential, there are certainly cases where cannabis use is problematic for patients. We want patients to become the best version of themselves, and to enable them to do this as seamlessly as possible. For some individuals, this may mean we recommend they immediately stop or reduce their cannabis usage, or they agree to specific plans to reduce its usage over time.
We fully support the physician-supervised medical use of cannabis and cannabinoids for appropriate medical indications where there exists a strong rationale for use, preferably with existing preclinical and clinical data that supports its effectiveness over or equivalence to the current clinical standard-of-care.
Like any medication with active pharmacological effects, there are well known side effects of cannabinoid treatments as well as drug-drug interactions, which will be discussed and managed with you in concert with our clinical team. Beyond this, there exist contraindications for cannabinoid therapy for with FDA-approved cannabinoid medications as well as in U.S. state medical cannabis legislation, which for instance may limit use of certain cannabinoid treatments to individuals age 25 or older, or which may not recommend use of certain cannabinoidsin patients with a history of mental illness. While the overall toxicity and harm potential of cannabinoid treatments may be very low compared to many existing prescription medications, including most notably opiate painkillers, it is not completely without risk. Each individual will be treated as an individual, trying to appropriately the weight the risks and benefits of treatment based on their medical history, current medications, social circumstances, genetics, and more, and in some cases our clinical team will advise against its use.